Immunological Study of IFNβ-1a-Treated and Untreated Multiple Sclerosis Patients: Clarifying IFNβ Mechanisms and Establishing Specific Dendritic Cell Immunotherapy

Publisher： Karger

E-ISSN： 1423-0216|12|1|29-44

ISSN： 1021-7401

Source： Neuroimmunomodulation, Vol.12, Iss.1, 2005-03, pp. : 29-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preferential Survival of an MBP-Specific T Cell Clone in an HLA-DR2 Multiple Sclerosis Patient

By  

Neuroimmunomodulation, Vol. 10, Iss. 1, 2002-08 ,pp. : 1-4

Karger

Access to resources Recommend Favorite

Effects of Interferon β-1a and Interferon β-1b Monotherapies on Selected Serum Cytokines and Nitrite Levels in Patients with Relapsing-Remitting Multiple Sclerosis: A 3-Year Longitudinal Study

By  

Neuroimmunomodulation, Vol. 20, Iss. 4, 2013-05 ,pp. : 213-222

Karger

Access to resources Recommend Favorite

Evidence of Prolactin Immunoreactivity in the Bone Marrow of Untreated Multiple Myeloma Patients

By  

Neuroimmunomodulation, Vol. 9, Iss. 2, 2001-09 ,pp. : 95-102

Karger

Access to resources Recommend Favorite

Interferon-β 1a Modulates Expression of RAGE but Not S100A12 and Nuclear Factor-κB in Multiple Sclerosis Patients

By  

Neuroimmunomodulation, Vol. 23, Iss. 5-6, 2017-04 ,pp. : 345-351

Karger

Access to resources Recommend Favorite

CD30 Antigen and Multiple Sclerosis: CD30, an Important Costimulatory Molecule and Marker of a Regulatory Subpopulation of Dendritic Cells, Is Involved in the Maintenance of the Physiological Balance between TH1/TH2 Immune Responses and Tolerance

By  

Neuroimmunomodulation, Vol. 12, Iss. 4, 2005-06 ,pp. : 220-234

Karger

Access to resources Recommend Favorite